Core Viewpoint - The company, Shanghai Youningwei Biotechnology Co., Ltd., has announced the use of idle self-owned funds for cash management, with a total limit of RMB 180 million, to enhance fund utilization efficiency and generate investment returns [1][6]. Group 1: Cash Management Plan - The company approved the use of up to RMB 30 million of idle raised funds and up to RMB 150 million of self-owned funds for cash management, effective for 12 months starting from March 9, 2025 [1]. - The cash management will involve low-risk investment products such as structured deposits and notice deposits [2][3]. Group 2: Risk Control Measures - The finance department will analyze and monitor the cash management products closely, maintaining communication with financial institutions to ensure fund safety [3]. - The internal audit department will conduct regular audits and verifications of the cash management fund usage [4]. Group 3: Impact on Daily Operations - The cash management initiative is designed to ensure the safety of the principal and will not affect the company's normal operations, aiming to improve fund efficiency and enhance company performance [6]. - The company has a history of using idle funds for cash management, with an outstanding balance of RMB 87.6 million in self-owned funds for structured deposits as of September 30, 2025 [7].